Search results
Found 2811 matches for
The ChAdOx1 nCov-2019 coronavirus vaccine, developed by teams at the University of Oxford, has been shown to trigger a robust immune response in healthy adults aged 56-69 and those over 70 years of age.
OVG Alumni
Browse the OVG Alumni, including those who have undertaken a PhD/DPhil, MSc or MD (a graduate degree in the UK for medical graduates) at OVG since 2001, with date of graduation and where available information on their current or most recent/notable role.